EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Predictors of 10-year radiographic joint damage in rheumatoid arthritis diagnosed 2006-2009: a prospective multicentre cohort study

Emma Eloff, Klara Martinsson, Kristina Forslind, Åsa Häggström, Anna Michaelsson, Mitra Linnerud Keshavarz, Anna Svärd, Ingrid Thyberg, Michael Ziegelasch, Alf Kastbom

Rheumatology Advances in Practice · 2026-11-12

DOI: 10.1093/rap/rkag145 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives To assess clinical and laboratory predictors of 10-year radiographic joint damage in contemporary recent-onset rheumatoid arthritis (RA). Methods The study is a prospective multicentre cohort with 10-year follow-up, including 160 patients with recent-onset RA 2006-2009 throughout the southern half of Sweden. X-ray images of hands, wrists and feet from baseline and follow-up were scored according to the Larsen method. Baseline laboratory and clinical data was related to 10-year progression of radiographic joint damage by linear regression analyses. Results Median Larsen score at baseline was 1.0 (IQR: 0.0 to 4.0), and 8.0 (IQR: 3.0 to 13) after 10 years, with a median progression of 5.0 (IQR: 1.3 to 9.8). In univariable analyses, higher 28-joint disease activity score (DAS28) at baseline, DAS28 at 6 months and age were associated with increased progression of Larsen score. In multivariable analyses, statistical significance remained for high disease activity (DAS28>5.1) at baseline (regression coefficient 0.27 p = 0.038). Anti-citrullinated protein antibodies and rheumatoid factor were not associated with progression of total Larsen score. Conclusion Radiographic damage after 10 years with RA was considerably lower in this study compared to historical cohorts with 10-year follow-up. Baseline disease activity remains an independent predictor of 10-year radiographic progression. Therefore, the initial presentation of the RA patient needs to be considered also in the long-term management. Since long-term radiographic damage is only partly explained by DAS28, our study highlights the need for additional prognostic tools to individualize therapeutic decisions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →